Hence GroPIns promotes CLL cell apoptosis by regulating the expression and activation of Bax through different pathways, highlighting the potential exploitability of this glycerophospholipid to overcome the apoptosis defects of CLL cells. The gene discussed is BAX; the disease is B-cell chronic lymphocytic leukemia.